POMSEGMY
Live / Allowed — Published for opposition (as of 14 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 12 Mar 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99697705
- Mark type
- Word mark
- Filed
- 12 Mar 2026
- Published for opposition
- 14 Jul 2026
- Attorney of record
- Andrea Christensen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 14 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jul 2026 — PUBLISHED FOR OPPOSITION
- 08 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jun 2026 — ASSIGNED TO EXAMINER
- 12 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Mar 2026 — NEW APPLICATION ENTERED